Huddinge, Sweden

Xiao-Xiong Zhou

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 1999-2012

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Xiao-Xiong Zhou

Introduction

Xiao-Xiong Zhou is a prominent inventor based in Huddinge, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target retroviruses such as HIV. With a total of 14 patents to his name, Zhou's work has the potential to impact the treatment of viral infections.

Latest Patents

Among his latest patents, Zhou has developed 1-[2', 3′-dideoxy-3′ C-(hydroxymethyl)—beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV inhibitors. These compounds are designed to be effective against reverse transcriptase mutants of HIV, allowing for the excision of chain-terminating nucleoside or nucleotide phosphates from nascent DNA strands. Additionally, he has worked on novel bicyclic tetrahydrofuran compounds and their pharmaceutically acceptable salts, which also hold promise in treating retroviral infections. His research includes acyclic nucleoside derivatives and methods for their preparation and treatment.

Career Highlights

Zhou is currently associated with Medivir AB, a company known for its focus on antiviral therapies. His innovative work in the pharmaceutical sector has positioned him as a key figure in the fight against viral diseases. His extensive patent portfolio reflects his commitment to advancing medical science and improving patient outcomes.

Collaborations

Zhou has collaborated with notable colleagues, including Per Engelhardt and Marita Hogberg, who contribute to the research and development efforts at Medivir AB. Their combined expertise enhances the potential for groundbreaking discoveries in antiviral treatments.

Conclusion

Xiao-Xiong Zhou's contributions to the field of pharmaceuticals, particularly in the development of HIV inhibitors, showcase his innovative spirit and dedication to improving healthcare. His work continues to pave the way for new treatments that could significantly benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…